Menu
Gilbert featured in extensive Brainport article

Gilbert featured in extensive Brainport article

Gilbert is proud to be featured in a publication of Brainport Eindhoven, titled ‘Innovation and Impact in Inhalation Therapy from the Heart of the Brainport Region’, being one of the MedTech Pioneers in the Brainport region. CEO Maurits Huigen and CCO Scott Fleming share their vision on the company and its Smart Precision Inhaler.

The article describes the university roots of the company and explains the potential of our disruptive, proprietary electrospray technology based, inhaler device and wide set of applications. Gilbert is proud and grateful to be part of the Brainport ecosystem, which has been instrumental to the success of the company so far.

The full article can be found here.

Gilbert is developing the next generation of soft mist inhalers based on a proprietary electrospray (Electro Hydrodynamic Atomization or EHDA) technology to redefine treatment for lung patients. Gilbert’s breath actuated smart precision inhaler creates a monodispersed soft mist aerosol, with a customizable droplet size enabling more precise targeting of drugs to desired regions of the lungs, which has the potential to improve the efficacy and safety of treatments. Electrospray enables gentle, efficient delivery of both small and large molecule therapies in both solution and suspension formulations.

Visit us at Gilbert | Redefining treatment for lung patients, follow us on Linkedin or contact us at info@gilbert.eu to learn if electrospray is suitable for your application.

Other posts

Interview with Mehmet Uzumcu

Mehmet Uzumcu talks about electrospray and its application in the […]
Read more

Interview with Scott Fleming

Gilbert's own Scott Fleming talks about Gilbert's Smart Precision Inhaler […]
Read more

Let’s stay in touch!

Stay up-to-date with Gilbert’s latest news, vacancies and achievements by following us on social media.

Follow us on LinkedIn